Zobrazeno 31 - 40
of 48
pro vyhledávání: '"59"'
Autor:
Jochen Metzger, William Mullen, Heiner V. Groesdonk, Angelique Stalmach, Matthias Klingele, Holger Husi, Stefan Herget-Rosenthal, Harald Mischak
Publikováno v:
Critical Care
Background Acute kidney injury (AKI) is a prominent problem in hospitalized patients and associated with increased morbidity and mortality. Clinical medicine is currently hampered by the lack of accurate and early biomarkers for diagnosis of AKI and
Proteomics investigation of breast cancer biomarkers in urine and blood for diagnosis and monitoring
Autor:
Beretov, Julia
Breast cancer (BC) is the most commonly diagnosed cancer among women in the world. Currently, there are no biomarkers available for early diagnosis and monitoring BC progression. Advances in proteomics technology have allowed new insight into cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38218591ed511d398b4325f3db909013
Autor:
Dimitrios, Farmakis, Thomas, Koeck, William, Mullen, John, Parissis, Bill D, Gogas, Maria, Nikolaou, John, Lekakis, Harald, Mischak, Gerasimos, Filippatos
Publikováno v:
European journal of heart failure. 18(7)
Urine proteome analysis (UPA) has already provided accurate discriminatory patterns of urinary peptides for renal disease, coronary artery disease, and asymptomatic LV diastolic dysfunction. UPA has now been used to characterize a discriminatory pept
Autor:
Lei Zhu, Zhanguo Li, Rulin Jia, Xiaozhen Zhao, Y. Cheng, Yuling Chen, Cibo Huang, Xiaolin Sun, Haiteng Deng, Yuhui Li
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0199047 (2018)
PLoS ONE
PLoS ONE
Background Behcet's disease (BD) is a chronic, multisystem-involved vasculitis and its pathogenesis remains elusive. No specific serological markers for BD diagnosis have been established. Identification of novel diagnostic biomarkers will be helpful
Publikováno v:
Journal of Proteome Research. 6:3456-3464
Rheumatoid arthritis, a debilitating, systemic inflammatory joint disease, is likely accompanied by alterations in circulating metabolites. Here, an 1H NMR spectroscopy-based metabolomics approach was developed to establish a metabolic 'biomarker pat
Autor:
Erik Malmström, Helena Frielingsdorf, Ellen Tufvesson, Lars Malmström, Maria Sennström, Erik A. Eklund, Anders Malmström, Gunilla Westergren-Thorsson, Maria F. Gomez, Gunvor Ekman-Ordeberg, Anna Holmberg
Publikováno v:
MHR: Basic science of reproductive medicine. 13:333-341
It is well established that fibroblasts play a crucial role in pathophysiological extracellular matrix remodelling. The aim of this project is to elucidate their role in normal physiological remodelling. Specifically, the remodelling of the human cer
Autor:
Carl R. Flannery, Elisabeth A. Morris, Zhiyong Yang, Wei Liu, Amanda Bemis, Eunice Wang, Yongchang Qiu, Jiang Wu
Publikováno v:
Arthritis & Rheumatism. 56:3675-3684
Objective To identify potential molecular mediators and biomarkers for osteoarthritis (OA), through comparative proteomic analysis of articular cartilage tissue obtained from normal donors without OA (n = 7) and patients with OA (n = 7). Methods The
Autor:
J K, Grubbs, C K, Tuggle, J C M, Dekkers, N J, Boddicker, Y T, Nguyen, E, Huff-Lonergan, D, Nettleton, S M, Lonergan
Publikováno v:
Journal of animal science. 93(4)
Improving the ability to predict livestock performance using biomarkers will provide a benefit for livestock genetic evaluation and improvement. The most practical biological sample to screen for development of biomarkers is serum due to the ease of
Autor:
Stephen M. Storm, Yves Dubaquie, Ji Gao, Leah-Ann Garulacan, Gregory J. Opiteck, Stanley A. Hefta, Estelle M. Fach, Qing Xiao
Publikováno v:
Molecular & Cellular Proteomics. 3:1200-1210
The purpose of this study was to identify in vitro and then prioritize a tractable set of protein biomarker candidates of atherosclerosis that may eventually be developed to measure the extent, progression, regression, and stability of atheroscleroti
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0170741 (2017)
PLoS ONE
PLoS ONE
Idiopathic pulmonary fibrosis (IPF) is a gradual lung disease with a survival of less than 5 years post-diagnosis for most patients. Poor molecular description of IPF has led to unsatisfactory interpretation of the pathogenesis of this disease, resul